Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Usana Health Sciences (USNA) Receivables Refunds (2016 - 2022)

Usana Health Sciences (USNA) has disclosed Receivables Refunds for 7 consecutive years, with $6.4 million as the latest value for Q4 2018.

  • On a quarterly basis, Receivables Refunds fell 26.22% to $6.4 million in Q4 2018 year-over-year; TTM through Dec 2018 was $6.4 million, a 26.22% decrease, with the full-year FY2018 number at $6.4 million, down 26.22% from a year prior.
  • Receivables Refunds was $6.4 million for Q4 2018 at Usana Health Sciences, down from $8.7 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $12.8 million in Q4 2016 to a low of $6.4 million in Q4 2018.
  • A 4-year average of $8.5 million and a median of $7.4 million in 2015 define the central range for Receivables Refunds.
  • Peak YoY movement for Receivables Refunds: surged 80.61% in 2016, then tumbled 32.14% in 2017.
  • Usana Health Sciences' Receivables Refunds stood at $7.4 million in 2015, then soared by 73.5% to $12.8 million in 2016, then crashed by 32.14% to $8.7 million in 2017, then dropped by 26.22% to $6.4 million in 2018.
  • Per Business Quant, the three most recent readings for USNA's Receivables Refunds are $6.4 million (Q4 2018), $8.7 million (Q4 2017), and $12.8 million (Q4 2016).